Aimmune Therapeutics Inc.

(AIMT) Trade

By |

Profile

Aimmune Therapeutics Inc is engaged in the field of biotechnology. It researches and develops drug candidates for the treatment of peanut and other food allergies.

Contact Information

Website: www.aimmune.com
Main Phone: +1 650 614-5220
Address: 8000 Marina Boulevard
Address 2: Suite 300
State: CA
City / Town: Brisbane
Country: USA
Postal Code: 94005-1884

Issuer Information

Exchange: NGS
CEO: Jayson Donald Alexander Dallas
Employees: 185
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 28.26 $ 1.63 (6.12%)
Last Price 28.26 Change $ 1.63 Change % 6.12 Tick N/A
Bid 28.23 Bid Size 100.00 Ask 28.28 Ask Size 100.00
Open 26.90 High 28.45 Low 26.84 Prev Close 26.63
Last Trade Volume 282,562 52 Wk Hi 42.00 52 Wk Low 24.56
Market Cap 1.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 58,477,440.00 EPS (TTM) -3.28 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 27 159
Number of Buys 15 67
Number of Sells 12 92
Net Activity 22500 -249363
Last 10 Buys Shares
Kathryn E. Falberg 1,000
Mark Iwicki 1,000
Eric H. Bjerkholt 1,000
Patrick G. Enright 1,000
Eric H. Bjerkholt 1,000
Patrick G. Enright 1,000
Patrick G. Enright 1,000
Patrick G. Enright 1,000
Patrick G. Enright 1,000
Patrick G. Enright 1,000
Last 10 Sell Shares
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
Stephen Dilly 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 80 80 80 80
Low Target Price Estimate 53 53 53 53
Mean Target Price Estimate 64 64 64 64
Standard Deviation 9.47 9.47 9.47 9.47
Date of Most Recent Estimate 05/31/18 05/22/18 05/22/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 7
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.13 1.13 1.13 1.13